Literature DB >> 9358162

Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1.

M Hsu1, P Inouye, L Rezende, N Richard, Z Li, V R Prasad, M A Wainberg.   

Abstract

Reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) has low fidelity compared with RTs of other retroviruses and cellular DNA polymerases. We and others have previously found that the fidelity of DNA-dependent DNA polymerization (DDDP) of M184V-mutated HIV-1 RT is significantly higher than that of wild-type RT. Viruses containing the M184V substitution are highly resistant to (-)-2'-dideoxy-3'-thiacytidine (3TC) in vitro and in patients treated with 3TC monotherapy. It was of interest to determine the fidelity of RNA-dependent DNA polymerization (RDDP) of M184V RT compared with wild-type because this step occurs first in reverse transcription; errors made during this step may be copied in subsequent polymerization steps. Using an in vitro mispaired primer extension assay, M184V-mutated RT exhibited 3-49-fold decreased frequency of mispair extension compared with wild-type RT. Fidelity differences between M184V and wild-type RT were most marked in extension of A:G (49-fold) and A:C (16-fold) mispairs, with only a marginal (3-fold) decrease in the extension of A:A mispairs. RT containing a methionine to isoleucine (M184I) mutation showed only slight increases in RDDP fidelity compared with wild-type, ranging from 1.5- to 6-fold increases. Of the three RTs tested, wild-type RT was the most error-prone, with mispair extension frequencies ranging from 6.674 x 10(-1) to 7.454 x10(-2).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358162      PMCID: PMC147088          DOI: 10.1093/nar/25.22.4532

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  Fidelity of human immunodeficiency virus type I reverse transcriptase in copying natural RNA.

Authors:  A Hübner; M Kruhoffer; F Grosse; G Krauss
Journal:  J Mol Biol       Date:  1992-02-05       Impact factor: 5.469

2.  Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition.

Authors:  C Majumdar; J Abbotts; S Broder; S H Wilson
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

3.  Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase.

Authors:  K Bebenek; J Abbotts; J D Roberts; S H Wilson; T A Kunkel
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

4.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

5.  Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography.

Authors:  S F Le Grice; F Grüninger-Leitch
Journal:  Eur J Biochem       Date:  1990-01-26

6.  Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.

Authors:  B B Oude Essink; N K Back; B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

7.  Fidelity of HIV-1 reverse transcriptase copying RNA in vitro.

Authors:  J P Ji; L A Loeb
Journal:  Biochemistry       Date:  1992-02-04       Impact factor: 3.162

8.  Fidelity of the reverse transcriptase of human immunodeficiency virus type 2.

Authors:  M Bakhanashvili; A Hizi
Journal:  FEBS Lett       Date:  1992-07-20       Impact factor: 4.124

9.  Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates.

Authors:  H Yu; M F Goodman
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

10.  Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Authors:  J C Boyer; K Bebenek; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more
  19 in total

Review 1.  Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Karidia Diallo; Matthias Götte; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

2.  HIV-1 Transmission, Replication Fitness and Disease Progression.

Authors:  Tasha Biesinger; Jason T Kimata
Journal:  Virology (Auckl)       Date:  2008-07-14

3.  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Authors:  Michael E Abram; Andrea L Ferris; Kalyan Das; Octavio Quinoñes; Wei Shao; Steven Tuske; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

4.  Increased misincorporation fidelity observed for nucleoside analog resistance mutations M184V and E89G in human immunodeficiency virus type 1 reverse transcriptase does not correlate with the overall error rate measured in vitro.

Authors:  W C Drosopoulos; V R Prasad
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket.

Authors:  Nootan Pandey; Chaturbhuj A Mishra; Dinesh Manvar; Alok K Upadhyay; Tanaji T Talele; Thomas W Comollo; Neerja Kaushik-Basu; Virendra N Pandey
Journal:  Biochemistry       Date:  2011-08-23       Impact factor: 3.162

6.  Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thio-5-fluorocytidine.

Authors:  N Richard; H Salomon; R Rando; T Mansour; T L Bowlin; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 7.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

8.  The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.

Authors:  P Gerondelis; R H Archer; C Palaniappan; R C Reichman; P J Fay; R A Bambara; L M Demeter
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity.

Authors:  Karidia Diallo; Bruno Marchand; Xin Wei; Luciano Cellai; Matthias Götte; Mark A Wainberg
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.

Authors:  Varuni K Jamburuthugoda; Jose M Santos-Velazquez; Mark Skasko; Darwin J Operario; Vandana Purohit; Pauline Chugh; Erika A Szymanski; Joseph E Wedekind; Robert A Bambara; Baek Kim
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.